Innovation in ADHD: Is it just more of the same?
The ADHD market is booming, with an 8.5% CAGR and estimated sales of $13.9 billion in 2024. Despite the growth, the pipeline seems stuck, reformulating longer-release versions of two existing stimulant drugs.